Johnson & Johnson (JNJ)

Bear markets are a normal part of investing, so you should always own some stocks that are resilient to market downturns.

All three are also solid "forever" holdings, but the next five years could be particularly exciting as each company bounces back from recent challenges.

IHE delivered 53.2% returns over one year with lower volatility and a 0.37% expense ratio, while PBE's quantitative biotech strategy carries higher risk.

Johnson & Johnson's new drugs may offset declining sales due to patent-protection losses.

Johnson & Johnson secures FDA clearance for MONARCH QUEST 3 software, boosting robotic bronchoscopy accuracy with AI. new 3D imaging tools.

While investors treat Wall Street like a casino, stick to these Buffett-style "wonderful investments."

The space company is popular right now, but these other corporations look more attractive.

Whether a recession is coming in 2026 or five years from now, the best investors are always figuring out how to prepare.

The pharmaceutical giant just increased its dividend by 3.1%, now paying $5.36 a share annually.

These stocks can help you withstand (almost) any storm.

Amazon, Microsoft, JPMorgan Chase, Johnson & Johnson and Coca-Cola posted strong earnings beats that held up, with cloud growth, capital returns and raised guidance fueling sustained stock gains.

VYM, VCIT, and AGG offer low-cost ETF options for income investors, combining dividend yields between 2.20% and 4.86% with broad diversification and expense ratios as low as 0.03%.

The pharmaceutical icon's dividend yield has been pared back by the stock's recent rally, driven by a new growth initiative.

They are going through a rough patch, but it's too early to give up on them.